The Enduring Role of Warfarin in Modern Cardiology
A new review in *Heart* reaffirms the critical place of vitamin K antagonists (VKAs) like warfarin in contemporary cardiovascular management. While direct oral anticoagulants (DOACs) are the standard for stroke prevention in atrial fibrillation and venous thromboembolism, the analysis identifies specific cardiac conditions where VKAs remain either preferred or where the evidence for DOACs is still uncertain. These key indications include patients with mechanical heart valves, atrial fibrillation complicated by moderate-to-severe mitral stenosis, and the presence of left ventricular or atrial thrombus. The authors argue that for these complex patient profiles, VKAs will continue to be a vital therapeutic tool, necessitating ongoing clinician expertise in their management.
Why it might matter to you: For critical care specialists managing complex shock states or post-cardiotomy patients, this review provides a crucial evidence-based framework for anticoagulation decisions. It directly informs the management of patients with mechanical circulatory support or intracardiac thrombi, where precise anticoagulant selection is paramount to balancing thrombotic and bleeding risks. This guidance helps refine protocols for high-acuity cardiovascular cases frequently encountered in the ICU.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
